RIBOTACs – targeting RNA to tackle genetic malignancies
Researchers at The Scripps Research Institute have used small molecules to help catalyze the breakdown of harmful RNA strands, with diseases such as cancer in their sights.
Please sign in or register for FREE
Sign in to RxNet
Register to RxNet
RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.